← Open Payments lookup

DALE ESSMYER: Open Payments

NPI 1770666984 · MILAN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$613 in 30 payments from 11 companies in 2025. Trend: 2023 $605 · 2024 $315 · 2025 $613

Food & beverage: $613
CompanyPaymentsAmount
ABBVIE INC.10$143
Novo Nordisk Inc1$102
Neurocrine BioSciences, Inc.3$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$76
Lundbeck LLC3$50
Kowa Pharmaceuticals America, Inc.3$43
UCB, Inc.2$36
Otsuka America Pharmaceutical, Inc.1$20
AstraZeneca Pharmaceuticals LP1$16
VERTEX PHARMACEUTICALS INCORPORATED1$15

Products named: Ozempic, INGREZZA, CAPLYTA, RINVOQ, REXULTI, VRAYLAR, ZORYVE, Bimzelx.

Industry payments across MO — which companies pay providers there.